NCT03320980
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
- Locations
-
Not specified
Clinical trial condition
Intrahepatic Cholangiocarcinoma
Explore clinical trials studying Intrahepatic Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
72 public trials
33 recruiting studies
Intrahepatic Cholangiocarcinoma trial results
NCT02762721
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
- Locations
-
- Atlanta, Georgia, United States
- Seattle, Washington, United States
- Rozzano, MI, Italy
- Benevento, Italy
Completed
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
NCT01668134
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT01954745
- Conditions
- Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +13 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT01862276
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Osaka University, Graduate School of Medicine Osaka, Japan
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Infusion System for Hepatic Cancer
NCT04684862
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Active, Not Recruiting
Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)
NCT04238637
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- University Hospital Dresden Dresden, Germany
- Clinic Essen Center Essen, Germany
- University Hospital Essen Essen, Germany
- University Hospital Halle Halle, Germany
Active, Not Recruiting
Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements
NCT05174650
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- HELIOS KLinikum Bad Saarow Bad Saarow, Germany
- MVZ am Oskar-Helene Heim Berlin Berlin, Germany
- Universitätsmedizin Berlin Charité Berlin, Germany
- Vivantes Klinikum Berlin Friedrichshain Berlin, Germany
Active, Not Recruiting
Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
NCT04669496
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
- Locations
-
- Zhongshan hospital Shanghai, Shanghai Municipality, China